Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5a35gqs15r
2. 252042-59-4
3. Phosphorylated Hexaacyl Disaccharide
4. [(2r,3s,4r,5r,6r)-2-(hydroxymethyl)-3-phosphonooxy-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]-6-[(2r,3s,4r,5r)-2,3,4-trihydroxy-6-oxo-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]hexoxy]oxan-4-yl] (3r)-3-tetradecanoyloxytetradecanoate
5. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-.beta.-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-
6. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-beta-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-
Molecular Weight | 1730.4 g/mol |
---|---|
Molecular Formula | C96H181N2O21P |
XLogP3 | 29.1 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 92 |
Exact Mass | 1730.29280262 g/mol |
Monoisotopic Mass | 1729.28944778 g/mol |
Topological Polar Surface Area | 347 Ų |
Heavy Atom Count | 120 |
Formal Charge | 0 |
Complexity | 2500 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?